FDA panel backs approval for Indivior opioid addiction drug

(Reuters) – Indivior Plc's experimental drug to treat opioid addiction is effective and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday.
Original Article

more recommended stories